Retinol-to-all-trans retinoic acid pathway leading to Hoxa1 gene expression

The retinol-to-all-trans retinoic acid (ATRA) pathway leading to Hoxa1 gene expression is a fundamental signaling axis in vertebrate development and cellular differentiation. This process begins with the uptake of retinol (Vitamin A), which is enzymatically oxidized to retinaldehyde by retinol dehydrogenases (RDHs) and subsequently to ATRA by retinaldehyde dehydrogenases, primarily ALDH1A2 (RALDH2) (Napoli, 2012, PMID: 22503486). ATRA then functions as a high-affinity ligand for nuclear retinoic acid receptors (RARs), which form heterodimers with retinoid X receptors (RXRs) to bind specific DNA sequences called retinoic acid response elements (RAREs) located in the regulatory regions of target genes like Hoxa1 (Chambon, 1996, PMID: 8624805). Hoxa1 is one of the most RA-sensitive genes and is essential for the specification of rhombomere identity in the developing hindbrain and craniofacial morphogenesis (Langston et al., 1997, PMID: 9230313). Pharmacological modulation of this pathway using retinoids like tretinoin is a cornerstone in treating acute promyelocytic leukemia and various dermatological conditions, though it carries significant risks of teratogenicity (Bushue & Wan, 2010, PMID: 20368179). Dysregulation of this axis is associated with developmental defects and various cancers, making its components, such as RARs and ALDH enzymes, significant therapeutic targets.

Other names

RA-Hoxa1 signaling axisRetinoid signaling pathwayVitamin A-Hoxa1 induction pathwayRetinoic acid-mediated Hoxa1 expression

Sequential enzymatic oxidation of retinol to all-trans retinoic acid (ATRA), followed by ATRA-induced activation of RAR/RXR heterodimers that bind to retinoic acid response elements (RAREs) in the Hoxa1 promoter to trigger transcription.